Bioter S.A. (ATH:BIOT)

Bioter Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0.39	1.26	0.5	0.25	0.25
Revenue Growth (YoY)	-69.00%	151.50%	98.02%	2.44%	7.90%
Cost of Revenue	0.23	0.3	0.55	0.27	1.18
Gross Profit	0.16	0.96	-0.05	-0.02	-0.94
Selling, General & Admin	2.03	12.95	2.43	1.42	0.51
Operating Expenses	2.03	12.95	2.43	1.42	0.51
Operating Income	-1.88	-11.99	-2.48	-1.43	-1.44
Interest Expense	-0.03	-10.96	-10.18	-9.53	-8.59
Interest & Investment Income	-	0.04	-	0.01	0.35
Earnings From Equity Investments	-	0.12	-	-	0.08
Other Non Operating Income (Expenses)	56.19	0.03	0.02	0.03	0.38
EBT Excluding Unusual Items	54.28	-22.77	-12.63	-10.92	-9.22
Gain (Loss) on Sale of Investments	-	-	-	-	-0.69
Gain (Loss) on Sale of Assets	-	-	0.35	-	-
Asset Writedown	-	0.34	0.25	0.76	0.77
Legal Settlements	-	0.15	-	-	-
Other Unusual Items	-	0.13	-	0.71	0.33
Pretax Income	54.28	-22.15	-12.03	-9.45	-8.8
Income Tax Expense	-0.16	-1.02	-0.26	0.21	0.02
Earnings From Continuing Operations	54.44	-21.13	-11.78	-9.66	-8.82
Minority Interest in Earnings	0.06	-0.13	0.1	-0.01	0.01
Net Income	54.49	-21.26	-11.68	-9.68	-8.81
Net Income to Common	54.49	-21.26	-11.68	-9.68	-8.81
Shares Outstanding (Basic)	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17
EPS (Basic)	3.26	-1.27	-0.70	-0.58	-0.53
EPS (Diluted)	3.26	-1.27	-0.70	-0.58	-0.53
Free Cash Flow	55.49	-12.05	-5.79	-9.46	-6.43
Free Cash Flow Per Share	3.32	-0.72	-0.35	-0.56	-0.38
Gross Margin	39.85%	76.33%	-9.62%	-5.95%	-
Operating Margin	-482.00%	-955.70%	-495.99%	-569.05%	-585.37%
Profit Margin	14008.48%	-1693.87%	-2340.88%	-3840.08%	-3580.89%
Free Cash Flow Margin	14265.30%	-960.32%	-1160.92%	-3753.18%	-2612.19%
EBITDA	-1.77	-11.9	-2.38	-1.34	-1.32
D&A For EBITDA	0.1	0.09	0.09	0.09	0.12
EBIT	-1.88	-11.99	-2.48	-1.43	-1.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.